Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Las Palmas de Gran Canaria

About this trial

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months).

The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

Eligibility criteria

Qualifiers

Meet the Budapest criteria for the clinical diagnosis of CRPS type I.

Age between 18 and 65.

Period between 0 and 6 months after the onset of the clinical picture.

Have signed the informed consent of their own free will.

Disqualifiers

Have a diagnosis of CRPS type II.

Present type I CRPS in more than one limb.

Patients who have suffered a recurrence of CRPS type I.

Pregnancy or plans for it during the study.

Trial design

Treatments tested in this trial

  • Non-invasive Neuromodulation

Treatment groups

42 Participants
are divided into 2 treatment groups